Dynacare Selects Lymphoma Canada as 2015 Lead Charity NewsPress Releases Dynacare Selects Lymphoma Canada as 2015 Lead Charity
Health Canada Approves ibrutinib for Mantle Cell Lymphoma NewsResearch Health Canada Approves ibrutinib for Mantle Cell Lymphoma
Specific subtype of diffuse large B-cell lymphoma more likely to respond to ibrutinib NewsResearch Specific subtype of diffuse large B-cell lymphoma more likely to respond to ibrutinib
Aggressive lymphoma linked to disruption in cell energy production NewsResearch Aggressive lymphoma linked to disruption in cell energy production
Newmarket Fundraiser in Support of Lymphoma Canada News Newmarket Fundraiser in Support of Lymphoma Canada